Condition: Colorectal Adenoma · Advanced Adenoma · Colorectal Polyp · Sponsor: Chinese University of Hong Kong
The investigators aim to evaluate the diagnostic accuracy of FIT and the novel panel of four bacterial gene markers collectively named as M3, to detect recurrent advanced adenomas in patients with history of colonic adenomas.
This description comes directly from the study's public registry record.
Min Dai · +85260490760 · mindai@link.cuhk.edu.hk
Connie Seto · +85260490760 · waiyiseto@cuhk.edu.hk
Always discuss trial participation with your own doctor first.
| Prince of Wales Hospital | Shatin, New Territories, Hong Kong | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05144152